Jpmorgan Chase & CO Oramed Pharmaceuticals Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ORMP
# of Institutions
62Shares Held
6.37MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.19MShares$5.22 Million3.14% of portfolio
-
Murchinson Ltd. Toronto, A61.7MShares$4.06 Million0.77% of portfolio
-
Boothbay Fund Management, LLC New York, NY825KShares$1.97 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$875,6982.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$692,6290.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $92.8M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...